BioStock: Alligator showcases bold drug development vision

Alligator Bioscience held its Capital Markets Day in Stockholm on December 1, 2023, offering investors, analysts, and media a comprehensive view of the company's pipeline and drug development strategy. Alligator’s CEO Søren Bregenholt shared the company’s long-term plan through 2030. Here, Bregenholt gives BioStock an in-depth overview of the key takeaways from Capital Markets Day.

Read the interview with Søren Bregenholt article at biostock.se:

Alligator showcases bold drug development vision - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/